1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63E70CC1C96F307946525821300351AAD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/3E70CC1C96F307946525821300351AAD!OpenDocument
18
19OpenDocument
2044.192.49.72
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Field Medical Excellence

Document Excerpt: Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies

DB Image

ID: MD-589


Features:

6 Info Graphics

24 Data Graphics

217 Metrics


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5489 "Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies".

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Biotech; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
Avanir; Boehringer Ingelheim; Galderma; GlaxoSmithKline ; Janssen; Medtronic; Merck; QuintilesIMS; Roche; Sanofi; Sunovion; Takeda Pharmaceuticals; Tide Pharmaceutical Company; UCB Pharma; ViiV Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.